Search

Your search keyword '"Buchholz, Tonia J."' showing total 7 results
Start Over Author "Buchholz, Tonia J." Publication Year Range Last 3 years
7 results on '"Buchholz, Tonia J."'

1. ABCL-412 Clinical Activity of CC-99282, a Novel, Oral, Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) –Results From CC-99282-NHL-001 (NCT03930953) a First-in-Human, Phase 1, Open-Label, Multicenter Study

Author

Chavez, Julio C., Michot, Jean-Marie, Carpio, Cecilia, Ferrari, Silvia, Feldman, Tatyana A., Morillo, Daniel, Kuruvilla, John, Pinto, Antonio, Ribrag, Vincent, Bachy, Emmanuel, Buchholz, Tonia J., Carrancio, Soraya, Chou, Wen-Chi, Guarinos, Carla, Wu, Fan, Li, Shaoyi, Patah, Poliana, Pourdehnad, Michael, and Nastoupil, Loretta

Published
2022
Full Text
View/download PDF

2. Supplementary Figure 2 from Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

Author

Demo, Susan D., primary, Kirk, Christopher J., primary, Aujay, Monette A., primary, Buchholz, Tonia J., primary, Dajee, Maya, primary, Ho, Mark N., primary, Jiang, Jing, primary, Laidig, Guy J., primary, Lewis, Evan R., primary, Parlati, Francesco, primary, Shenk, Kevin D., primary, Smyth, Mark S., primary, Sun, Congcong M., primary, Vallone, Marcy K., primary, Woo, Tina M., primary, Molineaux, Christopher J., primary, and Bennett, Mark K., primary

Published
2023
Full Text
View/download PDF

3. Data from Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

Author

Demo, Susan D., primary, Kirk, Christopher J., primary, Aujay, Monette A., primary, Buchholz, Tonia J., primary, Dajee, Maya, primary, Ho, Mark N., primary, Jiang, Jing, primary, Laidig, Guy J., primary, Lewis, Evan R., primary, Parlati, Francesco, primary, Shenk, Kevin D., primary, Smyth, Mark S., primary, Sun, Congcong M., primary, Vallone, Marcy K., primary, Woo, Tina M., primary, Molineaux, Christopher J., primary, and Bennett, Mark K., primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 1 from Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

Author

Demo, Susan D., primary, Kirk, Christopher J., primary, Aujay, Monette A., primary, Buchholz, Tonia J., primary, Dajee, Maya, primary, Ho, Mark N., primary, Jiang, Jing, primary, Laidig, Guy J., primary, Lewis, Evan R., primary, Parlati, Francesco, primary, Shenk, Kevin D., primary, Smyth, Mark S., primary, Sun, Congcong M., primary, Vallone, Marcy K., primary, Woo, Tina M., primary, Molineaux, Christopher J., primary, and Bennett, Mark K., primary

Published
2023
Full Text
View/download PDF

5. Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study

Author

Bal, Susan, primary, Kocoglu, M. Hakan, additional, Nadeem, Omar, additional, Htut, Myo, additional, Gregory, Tara, additional, Anderson, Larry D., additional, Costa, Luciano J., additional, Buchholz, Tonia J., additional, Ziyad, Safiyyah, additional, Li, Meng, additional, Chen, Yanping, additional, Kaeding, Allison J., additional, Burgess, Michael R., additional, Hege, Kristen, additional, and Berdeja, Jesus, additional

Published
2022
Full Text
View/download PDF

6. Poster: ABCL-412 Clinical Activity of CC-99282, a Novel, Oral, Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) –Results From CC-99282-NHL-001 (NCT03930953) a First-in-Human, Phase 1, Open-Label, Multicenter Study

Author

Chavez, Julio C., primary, Michot, Jean-Marie, additional, Carpio, Cecilia, additional, Ferrari, Silvia, additional, Feldman, Tatyana A., additional, Morillo, Daniel, additional, Kuruvilla, John, additional, Pinto, Antonio, additional, Ribrag, Vincent, additional, Bachy, Emmanuel, additional, Buchholz, Tonia J., additional, Carrancio, Soraya, additional, Chou, Wen-Chi, additional, Guarinos, Carla, additional, Wu, Fan, additional, Li, Shaoyi, additional, Patah, Poliana, additional, Pourdehnad, Michael, additional, and Nastoupil, Loretta, additional

Published
2022
Full Text
View/download PDF

7. Clinical Activity of CC-99282, a Novel, Oral Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients (Pts) with Relapsed or Refractory Non-Hodgkin Lymphoma (R/R NHL) - First Results from a Phase 1, Open-Label Study

Author

Michot, Jean-Marie, primary, Chavez, Julio C., additional, Carpio, Cecilia, additional, Ferrari, Silvia, additional, Feldman, Tatyana A., additional, Morillo, Daniel, additional, Kuruvilla, John, additional, Pinto, Antonio, additional, Ribrag, Vincent, additional, Bachy, Emmanuel, additional, Buchholz, Tonia J, additional, Carrancio, Soraya, additional, Guarinos, Carla, additional, Wu, Fan, additional, Li, Shaoyi, additional, Patah, Poliana, additional, Pourdehnad, Michael, additional, and Nastoupil, Loretta, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results